MYH9 and breast carcinoma: Moreover, the RFS of SIPA1high breast cancer patients with a high MYH9 expression was significantly lower than in patients with low MYH9 expression, while the RFS of BRCA patients with SIPA1low expression was not significant (Figure 6E,F).